David James Lennon insider trades

Open-market stock purchases and sales by David James Lennon, CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics, Inc, from SEC Form 4 filings since Oct 2, 2023.

Recent trades

DateStockTradeValue
Sep 15, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)—
Sep 15, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)—
May 14, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)$200K
Apr 9, 2026WHWK Whitehawk Therapeutics, IncSold$49K
Apr 8, 2026WHWK Whitehawk Therapeutics, IncSold$217K
Apr 7, 2026WHWK Whitehawk Therapeutics, IncSold$323K
Apr 6, 2026WHWK Whitehawk Therapeutics, IncSold$359K
Apr 2, 2026WHWK Whitehawk Therapeutics, IncSold$93.5K
Apr 1, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)—
Apr 1, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)—
Mar 2, 2026WHWK Whitehawk Therapeutics, IncSold$16.9K
Mar 1, 2026WHWK Whitehawk Therapeutics, IncBought (not open market)—

Companies traded

  • WHWK Whitehawk Therapeutics, Inc: 6 sales, last Sep 15, 2026
  • AADI Aadi Bioscience, Inc: 2 sales, last Mar 3, 2025

Get free alerts when David James Lennon files a new trade →